Sanjivani Parenteral Limited Reports Q1 FY27 Results; EBITDA stood at Rs. 43.21 Mn with PAT at Rs.…
Mumbai (Maharashtra) , August 14: Sanjivani Paranteral Limited (Sanjivani, The Company) (BSE: 531569), one of the emerging players in the pharmaceutical and healthcare manufacturing sector, continued to strengthen its operational…
Read More...
Read More...